“That would mean the monster sell-off has created some terrific buying opportunities,” Mad Money’s Cramer noted in the article. “I think Ponsi is dead right.”

IBB includes a 8.4% weight toward CELG and a 4.1% allocation in REGN.

iShares Nasdaq Biotechnology ETF

For more information on the biotech sector, visit our biotechnology category.